Cent Eur Neurosurg 2011; 72(4): 211-215
DOI: 10.1055/s-0029-1246137
Case Report
© Georg Thieme Verlag KG Stuttgart · New York

Intracranial Melanotic Schwannoma: A Case Report of Recurrence with Extra- and Intradural Manifestation Two Decades After Initial Diagnosis and Treatment

C. Ditz1 , K. Brunswig1 , C. Meyer1 , E. Reusche2 , G. Nowak1 , V. Tronnier1
  • 1UK-SH, Neurosurgery, Lübeck, Germany
  • 2UK-SH, Neuropathology, Lübeck, Germany
Further Information

Publication History

Publication Date:
22 April 2010 (online)


Melanotic schwannoma (MS) is a very rare nerve sheath tumor characterized by melanin-producing cells that display ultrastructural features of Schwann cells [24]. This type of tumor was first described in 1932 [17] and occurs primarily in the paraspinal region, originating from the spinal nerve roots or sympathetic ganglia. Craniofacial or intracranial locations are rare [15] [21]. However, extraneural locations such as skin, soft tissues, bone and viscera have also been described [5] [7]. In a minority of cases, MS may have multiple nodules [6] [26]. Although MS have been considered to be slow-growing, benign tumors, prognosis can be poor as a result of local recurrence or malignant progression [9]. Melanotic schwannoma occurs in relatively young adults (mean age 35 years) and have no sex predilection. Epidemically, two types of tumors can be distinguished: the sporadic variant and psammomatous melanotic schwannoma associated with the Carney complex, a rare, autosomal dominant hereditary syndrome characterized by variegated skin pigmentation, cardiac myxomas, endocrine overactivity, and nerve sheath tumors [2]. Psammoma bodies are present in more than 50% of MS. Immunohistochemistry reveals that S100, HMB-45 and vimentin are strongly expressed by most cells in MS [15] [18].



Dr. C. Ditz

UK-SH Campus Lübeck Neurosurgery

Ratzeburger Allee 160

23538 Lübeck


Phone: +49/451/500 2076

Fax: + 49/451/500 6191

Email: claudia.ditz@gmx.de